Can Biotech ETFs Continue to Soar in 2020?

<pre> We discuss coronavirus, cancer drugs, gene therapies, crispr and related biotech stocks & ETFs.<br /><br />(1:20) - Who Could Benefit From A Coronavirus Treatment?<br />(5:45) - What Should Investors Expect From Biotech In 2020?<br />(10:50) - Will The FDA Approve Biogen’s New Alzheimer’s Drug?<br />(15:00) - New and Exciting Cancer Treatments<br />(22:15) - CRISPR: Is 2020 The Year For Gene Therapy?<br />(32:40) - Merck’s Product Spin Off<br /> <a href="mailto:Podcast@Zacks.com" target="_blank" rel="noopener noreferrer">Podcast@Zacks.com</a> </pre>